metformin has been researched along with Aortic Aneurysm, Ruptured in 5 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using nationwide Danish registry data, we performed a nested case-control study on the association between long-term use of metformin and ruptured abdominal aortic aneurysm (RAAA)." | 7.85 | Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms. ( Hallas, J; Kristensen, KL; Lindholt, JS; Pottegård, A; Rasmussen, LM, 2017) |
| "Currently there is no drug therapy for abdominal aortic aneurysm (AAA) and most previous investigations have focused on imaging rather than clinical outcomes." | 5.51 | Editor's Choice - Metformin Prescription is Associated with a Reduction in the Combined Incidence of Surgical Repair and Rupture Related Mortality in Patients with Abdominal Aortic Aneurysm. ( Bourke, B; Bourke, M; Golledge, J; Jenkins, J; Jones, R; Morris, DR; Moxon, JV; Norman, PE; Pinchbeck, J; Rowbotham, S, 2019) |
| "To assess the association of metformin prescription with the risk of aortic aneurysm, aortic aneurysm events and the enlargement of abdominal aortic aneurysm (AAA)." | 5.01 | Metformin prescription and aortic aneurysm: systematic review and meta-analysis. ( Cao, S; Chen, T; Durgahee, MSA; Jiang, D; Wang, J; Wang, K; Wang, R; Wei, X; Yu, X, 2019) |
| "Using nationwide Danish registry data, we performed a nested case-control study on the association between long-term use of metformin and ruptured abdominal aortic aneurysm (RAAA)." | 3.85 | Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms. ( Hallas, J; Kristensen, KL; Lindholt, JS; Pottegård, A; Rasmussen, LM, 2017) |
| "Currently there is no drug therapy for abdominal aortic aneurysm (AAA) and most previous investigations have focused on imaging rather than clinical outcomes." | 1.51 | Editor's Choice - Metformin Prescription is Associated with a Reduction in the Combined Incidence of Surgical Repair and Rupture Related Mortality in Patients with Abdominal Aortic Aneurysm. ( Bourke, B; Bourke, M; Golledge, J; Jenkins, J; Jones, R; Morris, DR; Moxon, JV; Norman, PE; Pinchbeck, J; Rowbotham, S, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, R | 3 |
| Liu, Y | 3 |
| Jiang, J | 3 |
| Lareyre, F | 1 |
| Raffort, J | 1 |
| Kristensen, KL | 1 |
| Pottegård, A | 1 |
| Hallas, J | 1 |
| Rasmussen, LM | 1 |
| Lindholt, JS | 1 |
| Golledge, J | 1 |
| Morris, DR | 1 |
| Pinchbeck, J | 1 |
| Rowbotham, S | 1 |
| Jenkins, J | 1 |
| Bourke, M | 1 |
| Bourke, B | 1 |
| Norman, PE | 1 |
| Jones, R | 1 |
| Moxon, JV | 1 |
| Yu, X | 1 |
| Jiang, D | 1 |
| Wang, J | 1 |
| Wang, R | 1 |
| Chen, T | 1 |
| Wang, K | 1 |
| Durgahee, MSA | 1 |
| Wei, X | 1 |
| Cao, S | 1 |
2 reviews available for metformin and Aortic Aneurysm, Ruptured
| Article | Year |
|---|---|
Research advances in drug therapy for abdominal aortic aneurysms over the past five years: An updated narrative review.
Topics: Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Aortic Rupture; Humans; Hydroxymethylglutaryl-CoA | 2023 |
Research advances in drug therapy for abdominal aortic aneurysms over the past five years: An updated narrative review.
Topics: Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Aortic Rupture; Humans; Hydroxymethylglutaryl-CoA | 2023 |
Research advances in drug therapy for abdominal aortic aneurysms over the past five years: An updated narrative review.
Topics: Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Aortic Rupture; Humans; Hydroxymethylglutaryl-CoA | 2023 |
Research advances in drug therapy for abdominal aortic aneurysms over the past five years: An updated narrative review.
Topics: Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Aortic Rupture; Humans; Hydroxymethylglutaryl-CoA | 2023 |
Metformin prescription and aortic aneurysm: systematic review and meta-analysis.
Topics: Aortic Aneurysm, Abdominal; Aortic Rupture; Diabetes Mellitus; Disease Progression; Drug Prescriptio | 2019 |
3 other studies available for metformin and Aortic Aneurysm, Ruptured
| Article | Year |
|---|---|
Metformin to Limit Abdominal Aortic Aneurysm Expansion: Time for Clinical Trials.
Topics: Aortic Aneurysm, Abdominal; Aortic Rupture; Humans; Hypoglycemic Agents; Metformin | 2021 |
Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms.
Topics: Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal; Aortic Rupture; Case-Control Studies; Denmark; | 2017 |
Editor's Choice - Metformin Prescription is Associated with a Reduction in the Combined Incidence of Surgical Repair and Rupture Related Mortality in Patients with Abdominal Aortic Aneurysm.
Topics: Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal; Aortic Rupture; Australia; Cohort Studies; Cost | 2019 |